Adebrelimab: Clinical Trials

19 trials of Adebrelimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 5 not yet recruiting, 4 unknown, 1 active not recruiting. 19 Phase 1, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 119Recruiting 8, Not yet recruiting 5, Unknown 4, Active not recruiting 1, Completed 1
Phase 210Recruiting 4, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Completed 1

Follow Adebrelimab: new trials by email Literature Review of Adebrelimab trials Research Report on Adebrelimab

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
HRS-2329 Tablet, Nimotuzumab, HS-20093 - Pancreatic Cancer, RAS Mutations or Amplifications
Phase 1 / Phase 2Not yet recruitingZhejiang University802026-08-152026-08-31
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Propranolol Hydrochloride, Adebrelimab, Chemotherapy - Small Cell Lung Cancer (SCLC)
Phase 1RecruitingSecond Xiangya Hospital of Central South University182026-05-292026-10-21
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Adebrelimab, Gemcitabine + Cisplatin, Simvastatin 20mg - Advanced Biliary Tract Carcinoma
Phase 1 / Phase 2RecruitingTongji Hospital292026-01-302026-03-23
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
SHR-A2102, Adebrelimab, Cetuximab - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.2102025-07-112026-07-20
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
HS-10370, HS-20117, Adebrelimab - Advanced Solid Tumors, Colorectal Cancer
Phase 1Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.7622025-05-302025-05-09
ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.
HS-20093, Anlotinib, Epirubicin - Osteosarcoma, Soft Tissue Sarcoma (STS)
Phase 1Not yet recruitingHansoh BioMedical R&D Company4482024-12-202024-11-21
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors
HS-10370, Adebrelimab, Cisplatin - Non-Small Cell Lung Cancer, Advanced Solid Tumors
Phase 1Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.3502024-10-312024-09-19
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Adebrelimab - Gastric Cancer
Phase 1 / Phase 2RecruitingCancer Hospital Chinese Academy of Medical Science, Shenzhen Center522024-08-032025-01-15
A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
HRS-4642, Adebrelimab, SHR-9839 - Advanced KRAS G12D Mutant Solid Tumors
Phase 1 / Phase 2Active not recruitingJiangsu HengRui Medicine Co., Ltd.472024-07-052025-09-19
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
HRS-4642, Adebrelimab, SHR-8068 - Pancreatic Cancer
Phase 1 / Phase 2RecruitingFudan University1302024-06-172026-05-26
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
HRS2398, Adebrelimab - Advanced Solid Tumors
Phase 1 / Phase 2UnknownShanghai Hengrui Pharmaceutical Co., Ltd.882024-06-122024-07-05
SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer
SHR-8068, Adebrelimab, BP102 - Colorectal Cancer
Phase 1 / Phase 2Not yet recruitingWest China Hospital362024-05-012024-04-18
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
HS-20093, Adebrelimab, Cisplatin/ Carboplatin - Advanced Solid Tumor
Phase 1RecruitingHansoh BioMedical R&D Company6102024-04-262024-07-18
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
HS-20089, Adebrelimab, Bevacizumab - Advanced Solid Tumors
Phase 1RecruitingHansoh BioMedical R&D Company10482024-04-112024-07-18
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
Adebrelimab, Dalpiciclib 100mg, Dalpiciclib 150mg - Esophageal Squamous Cell Carcinoma
Phase 1UnknownWest China Hospital62023-12-292024-03-06
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
Adebrelimab, Apatinib, Gemcitabine - Biliary Tract Malignancies
Phase 1RecruitingFirst Affiliated Hospital of Fujian Medical University352023-12-232024-04-30
A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors
HRXG-K-1939, Adebrelimab - Advanced Solid Tumors
Phase 1UnknownFudan University302023-07-012023-07-12
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Adebrelimab, SHR-1802, Carboplatin/Cisplatin - Advanced Solid Tumor
Phase 1 / Phase 2CompletedShanghai Hengrui Pharmaceutical Co., Ltd.162023-04-282026-11-13
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
Adebrelimab, Bevacizumab, SHR-8068 - Advanced Hepatocellular Carcinoma
Phase 1 / Phase 2UnknownSuzhou Suncadia Biopharmaceuticals Co., Ltd.1292022-08-022024-06-21

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Colorectal Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Osteosarcoma (1)  ·  Sarcoma (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Sponsors

Hansoh BioMedical R&D Company (3)  ·  Fudan University (2)  ·  Jiangsu Hansoh Pharmaceutical Co., Ltd. (2)  ·  Shanghai Hengrui Pharmaceutical Co., Ltd. (2)  ·  Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2)  ·  West China Hospital (2)  ·  Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1)  ·  First Affiliated Hospital of Fujian Medical University (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Second Xiangya Hospital of Central South University (1)  ·  Tongji Hospital (1)  ·  Zhejiang University (1)

Countries

China (17)

Top investigators

Jin Zhou, MD.,PhD. (1)  ·  Maolin Yan (1)  ·  Wanguang Zhang, M.D. (1)  ·  Yufeng Chen (1)  ·  Zeyang Ding, M.D. (1)